CYDY - CytoDyn: Reliable In All The Wrong Places
- CytoDyn is a little biotech that has worked diligently but unsuccessfully to develop a single therapy, variously named Pro 140, leronlimab, and Vyrologix.
- In development of this therapy, CytoDyn has cast its net far and wide both geographically and in terms of potential indications.
- CytoDyn's inventories of leronlimab are building up, whether they will ever be used is an open question.
- While CytoDyn has been dawdling, market opportunities for leronlimab as a combination therapy in the treatment of multi-drug-resistant HIV have been closing.
For further details see:
CytoDyn: Reliable In All The Wrong Places